AGP Executive Report
Last update: an hour agoImmunization & Public Health: Ontario is adding CAPVAXIVE® to its publicly funded adult pneumococcal immunization program, expanding access for eligible older adults. Clinical Research & Drug Updates: AbbVie reports positive phase 3 results for atogepant in menstrual migraine prevention, while new analyses highlight that PPV23 vaccination wasn’t clearly linked to lower cardiovascular risk and that GLP-1 success should be judged by metabolic quality, not just weight loss. Workplace Health & Negotiations: CUPE 5430 says it’s seen movement in Saskatchewan health-care bargaining after job-action support, including some monetary changes. Rare Disease Awareness: A Sudbury family shares its Rett syndrome story as Lumina’s diagnosis reshaped her life and care needs. Health System & Services: MedLegalPsych launches independent psychiatric assessment and IME services in Winnipeg for insurers, employers and disability case managers. Care Access & Safety: A nurse in Nunavut challenges a workers’ compensation denial after an ATV hit her, arguing she wasn’t supported during recovery. Wellness Industry: CHFA’s 2026 Industry Achievement Awards spotlight leaders across Canada’s health-food and wellness sector, including Mitsoh as Trailblazer Small Business winner.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.